ask="6.00"
ask_size="200"
average_daily_volume="1421510"
bid="5.30"
bid_size="2000"
book_value="-0.08"
change="-0.18"
change_from_200_day_moving_average="0.23"
change_from_50_day_moving_average="0.35"
change_from_52_week_high="-2.27"
change_From_52_week_low="1.50"
change_in_percent="-3.15%"
close="5.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.52"
ebitda="-121.76M"
eps_estimate_current_year="-0.67"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="72994000"
high="5.76"
high_52_weeks="7.80"
last_trade_date="3/16/2017"
last_trade_price="5.53"
last_trade_size="52000"
last_trade_time="4:00pm"
low="5.48"
low_52_weeks="4.03"
market_capitalization="595.40M"
moving_average_200_day="5.30"
moving_average_50_day="5.18"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="5.69"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+4.27%"
percent_change_from_50_day_moving_average="+6.70%"
percent_change_from_52_week_high="-29.10%"
percent_change_from_52_week_low="+37.22%"
previous_close="5.71"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="19.22"
revenue="31.98M"
shares_outstanding="107667000"
short_ratio="15.22"
stock_exchange="NCM"
symbol="KERX"
volume="1136550"
weeks_range_52="4.03 - 7.80"
